W. Giaretti et al., INTRATUMOR HETEROGENEITY OF K-RAS2 MUTATIONS IN COLORECTAL ADENOCARCINOMAS, The American journal of pathology, 149(1), 1996, pp. 237-245
Detailed information about intratumor K-ras2 mutations in colorectal a
denocarcinomas and a possible association with DNA content heterogenei
ty is still lacking. DNA diploid and aneuploid subclones, detected amo
ng multiple histologically selected primary sectors (57 superficial an
d 40 deep) and 9 lymph node metastases, were flow cytometrically sorte
d and separately submitted to codons 12-13 K-ras2 mutation spectrum an
alysis. DNA aneuploidy was absent among 20 near and 20 distant mucosa
sites and present in 7/9 lymph node metastases and in 17/19 primary tu
mors (90%). Primary intratumor DNA multiclonality was approximately 50
%. Degree of DNA aneuploidy (DNA Index) distribution was nonrandom and
showed peaks at approximate mean DNA index values of 1.2, 1.5, and 1.
8. K-ras2 mutations were detected in 0/20 mucosa cases, in 2/9 lymph n
ode metastases, and in 9/19 adenocarcinomas (47%). No more than one mu
tation type per tumor was detected. Intratumor distribution of K-ras2
mutations was homogeneous in 6 and heterogeneous in 3 cases. Homogeneo
us distribution was associated with DNA near-diploid aneuploidy. K-ras
2 mutations were strongly associated with DNA Index in the near-diploi
d region (83%) and almost absent (5%) among DNA near-triploid subclone
s (P = 0.0001). K-ras2 mutation intratumor heterogeneity indicates tha
t sampling of the tumor may be a critical step and suggests that K-ras
2 activation may be a late event in a subgroup of tumors. Our data als
o suggest the existence of an early process of the colorectal carcinog
enesis that favors both K-ras2 mutations and DNA near-diploid aneuploi
dy. Onset of DNA near-triploid subclones appears, instead, to be indep
endent from K-ras2 activation.